5 Best Dividend Stocks To Buy According To Warren Buffett

2. AbbVie Inc. (NYSE:ABBV)

Berkshire Hathaway’s Stake Value: $2,312,258,000
Percent of Berkshire Hathaway’s 13F Portfolio: 0.78%
Number of Hedge Fund Holders: 82
Dividend Yield: 4.68%

As of Q2 2021, Berkshire Hathaway owns 20.5 million shares in AbbVie Inc. (NYSE:ABBV), valued at $2.3 billion. The company accounts for 0.78% of the hedge fund’s 13F portfolio. In September, JPMorgan lifted its price target on AbbVie Inc. (NYSE:ABBV) to $140, while keeping an ‘Overweight’ rating on the shares. The company pays an annual dividend of $5.20 per share, yielding 4.68%. AbbVie Inc. (NYSE:ABBV) has been growing its dividend for the past 49 years and its 3-year dividend growth stood at 84.3%. In Q2 2021, AbbVie Inc. (NYSE:ABBV) posted an EPS of $3.11, beating the estimates by $0.08. In the past year, the stock returned 26.77%. 

The number of hedge funds having stakes in the company grew to 82 in Q2, compared with 72 in the previous quarter. The total value of these stakes is $5.35 billion.